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Abstract
Background Despite the well-known health beneﬁts of physical activity, it is a great challenge to stay physically active for
frail–older adults with mobility limitations. The aim of this study was to test the (cost-) effectiveness of a patient-centred
physical therapy strategy (Coach2Move) in which individualized treatment (motivational interviewing, physical examination,
individualized goal setting, coaching and advice on self management, and physical training) is combined to increase physical
activity level and physical ﬁtness and, thereby, to decrease the level of frailty.
Methods A randomized controlled trial was performed in 13 physical therapy practices with measurements at 3 and
6months. Eligible patients were aged 70 years or over and had mobility problems (i.e. difﬁculties with walking, moving, getting
up and changing position from bed or chair to standing, or stair climbing). The primary outcome was physical activity (total and
moderate intensity) in minutes per day. Secondary outcomes were as follows: frailty, walking speed and distance, mobility, and
quality of life. Data were analysed using linear mixed models for repeated measurements. Healthcare costs and quality-
adjusted life years (QALYs) were computed and combined using net monetary beneﬁt (NMB) for different willingness to pay
thresholds. Data on costs, QALYs, and NMBs were analysed using linear mixed models.
Results One hundred and thirty patients participated in this study. At 6months, the between-group difference was signiﬁ-
cant for moderate-intensity physical activity in favour of the Coach2Move group [mean difference: 17.9min per day; 95%
conﬁdence interval (CI) 4.0 to 34.9; P = 0.012]. The between-group difference for total physical activity was 14.1min per day
(95% CI 6.6 to 34.9; P = 0.182). Frailty decreased more in the Coach2Move group compared with usual care [mean
difference: 0.03 (95% CI: 0.06 to 0.00; P = 0.027)]. Compared with usual treatment, the Coach2Move strategy resulted
in cost savings (€849.8; 95% CI: 1607 to 90; P = 0.028), an improvement in QALYs, (0.02; 95% CI: 0.00 to 0.03; P = 0.03), and
a higher NMB at every willingness to pay threshold.
Conclusions Older adults with mobility problems are able to safely increase physical activity in their own environment and
reduce frailty. This study emphasizes both the potential cost-effectiveness of a patient-centred approach in the frail elderly and
the importance of physical activity promotion in older adults with mobility limitations.
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Introduction
Physical activity (PA) is known to be of substantial value in
the prevention and treatment of many chronic diseases1
and disease-related status such as decreased physical
functioning,2 mobility limitations,3 sarcopenia,4,5 anxiety,
and depression.6 In addition, PA has a positive inﬂuence on
quality of life7 and is thought to be the most promising inter-
vention to prevent and reduce frailty status in older adults.8,9
Frailty refers to a reduced reserve capacity leading to an
increased risk of adverse health outcomes such as disability,
falls, hospital admission, and death.10 In fact, reduced PA is
often the result of sarcopenia, fatigue, a period of bed rest,
fear of falling, and so on. However, at the same time, reduced
PA causes reduced walking speed, muscle strength, endur-
ance, and loss of co-ordination, which in turn increases the
risk of negative health outcomes.11 Moreover, psychological
and social factors are also involved in this vicious cycle:
mobility limitations are associated with, for example, depres-
sion and increasing loneliness.12,13
Although the health beneﬁts of PA are widely known and
recognized, it is a great challenge to increase PA in older
adults with already existing limitations in physical function-
ing.2 Many older adults remain or become sedentary after
acute illnesses (e.g. stroke, fractures, and infections with a
long period of bed rest) or life events (social isolation),
despite the advice to stay physically active by, for instance,
participating in exercise programmes.14 Globally, 31% of the
population does not meet the PA standards of 30min of
moderate intensity PA on 5 to 7 days per week.1 In the UK,
only 9% of older adults of 75 years and over adhered to the
PA standard in 2008,13 whilst in the Netherlands, this
percentage was 49% (in older adults aged 65 years or over)
in 2011.15 Even though the adherence rates vary in different
countries, it is clear that globally, a substantial proportion of
older adults is sedentary and that inactivity increases with
increasing age and mobility difﬁculties.14 A more patient-
centred intervention seems to be necessary, especially if
mobility is threatened by sarcopenia, chronic conditions, or
acute physical or social events.16–18
Patient centredness is considered to be one of the means
to improve healthcare systems by achieving better health
outcomes, greater patient satisfaction, and reduced health
costs.19 Activities identiﬁed as being relevant for patient-
centred care are as follows: patient information, patient
involvement (shared decision-making), involvement of family
and friends, patient empowerment (self-management), phys-
ical support, and emotional support. We developed a physical
therapy strategy to improve PA in older adults with mobility
problems that includes these patient-centred activities. The
patient-centred strategy under study was designed using
the Medical Research Council20,21 recommendations for
designing complex interventions and was based on both
extensive literature studies and expert consultation including
consultation with older adults with mobility problems. Our
hypothesis underlying the intervention was to focus on
training of physical disabilities as detected in the physical
examination and to increase the PA level leading to a
decreased level of frailty. At the same time, we tried to
increase adherence to PA and training and self-efﬁcacy by
detecting the individual social needs, by taking away contex-
tual barriers and, by giving concrete feedback during the
training on goal attainment (e.g. gait velocity). The potential
effectiveness of the Coach2Move strategy on PA, physical ﬁt-
ness and mobility, and thereby frailty and quality of life was
shown in a pilot study, which justiﬁed a larger randomized
controlled trial (RCT).22
The aim of the present RCT was to test the Coach2Move
strategy on (cost-) effectiveness. We expected the
Coach2Move strategy to be more effective than usual care
physical therapy in improving PA and, as a consequence,
frailty and quality of life. The Coach2Move strategy and usual
care physical therapy were both expected to improve
mobility. In addition, we expected the Coach2move strategy
to be more cost effective than usual care physical therapy
because of themore patient-centred focus, increased adherence,
self-efﬁcacy, and expected reduction in frailty.
Methods
Design
The design of this study was an RCT in 13 physical therapy
practices. All older adults (≥70 years old) who, because of
mobility problems, had signed up for physical therapy in a
participating practice were invited to participate before they
were seen by a physical therapist. When willing to participate,
potential eligibility was determined by the research team via
a telephone call, and, in cases of eligibility, an appointment
was made for the baseline measurement. All measurements
took place either in the patient’s home or at the physical
therapy practice where the patient would receive treatment.
Written informed consent was signed at the start of the base-
line measurement. A detailed description of the trial protocol
has been outlined elsewhere.23
Setting and participants
Participants were older adults aged 70 years or over who had
signed up for physical therapy because of mobility problems.
Mobility problems in our subjects were problems related to
walking either inside or outside of the house, stair climbing,
getting into or out of a bed or a chair, standing up from the
ﬂoor, and so on.24,25 In addition, potential participants had
a sedentary lifestyle or were at risk of losing an active lifestyle
in the near future (as rated by the participant, relatives, or a
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referring physician). At-risk patients were patients who had
recently fallen and showed fear avoidance behaviour, or pa-
tients who showed reduced co-ordination and unstable gait
patterns or decreased gait velocity. These problems can lead
to a downward vicious cycle of inactivity and related physical
problems such as sarcopenia, mobility limitations, and
disability leading to social isolation. Exclusion criteria were
as follows: (i) unable to walk 5m (walking aid allowed); (ii)
unable to follow verbal or written instructions because of
cognitive problems (minimal mental state examination
score< 21) or unable to understand the Dutch language;
(iii) palliative phase of illness; (iv) acute illness with hospital
indication; (v) living in a nursing home; (vi) severe degenera-
tive neurological disease; (vii) having a contraindication to be
physically active; and (viii) had physical therapy for a period
longer than 4weeks during the last 6months.
Randomization
Randomization was prepared at patient level for each
physical therapy practice using a computer-generated
random-sequence table by a researcher not involved in
patient inclusion. After the baseline measurement, a sealed
envelope securing randomization concealment, containing a
sheet of paper indicating one of the two interventions, was
delivered to the practice secretary or physical therapist.
Patients were informed about their treating therapist after
the research assistant involved in the baseline measurement
had left. Physical therapy was given according to the
Coach2Move strategy by an educated geriatric physical
therapist and usual care physical therapy by a physical therapist
without this additional education in geriatrics. All participating
physical therapists had a comparable amount of clinical experi-
ence. Patients were not informed of whether they were in the
‘experimental’ or ‘control’ group. Follow-up measurement at 3
and 6months was performed by research assistants who were
not aware of group allocation.
Intervention
The Coach2Move strategy is developed in several phases
conforming to the phases of the Medical Research Council
framework.20,21 Using the theoretical construct of Fried and
Rockwood,11,26 the hypothesis-oriented algorithm for
clinicians27,28 and the results of two systematic reviews2,29
are combined with an analysis of daily practice and the per-
ceptions of patients and healthcare providers. Coach2Move
helps geriatric physical therapists by providing a patient-
centred approach of supporting clinical reasoning to detect
needs, limitations, and strength in both the patient and the
physical and social environment and choosing evidence-
based interventions taking into account co-morbidity. Clinical
reasoning is stimulated by using an extensive, pre-structured,
systematically organized, hypothesis-oriented diagnostic pro-
tocol supported by an electronic health record. Based on this
comprehensive intake, a stratiﬁed, goal-oriented treatment
plan that ﬁts the preferences, needs, and barriers of the pa-
tient and his or her environment is designed. The patient is
categorized according to one of three intervention proﬁles
with a pre-deﬁned number of consults based on expected re-
covery. Switching between proﬁles was allowed and, despite
the advice given on a maximum number of consults, the ge-
riatric physical therapist could deviate when appropriate to
reach the determined goals. The geriatric physical therapist
coaches and motivates the patient to increase adherence to
PA using feedback on goal attainment in all intervention pro-
ﬁles. Participating geriatric physical therapists were educated
in the Coach2Move strategy during a 2 days training (Table 1).
From the patient perspective, treatment according to the
Coach2Move strategy means a more detailed examination,
active involvement in decisions on (meaningful) treatment
goals, appropriate evidence-based intervention (shared
decision-making), and active involvement in and feedback on
reaching these goals in which family, friends, or (informal)
caregivers are involved.
To facilitate the intake and achieve a detailed examination,
ﬁnances were given to the participants to prolong the intake
session from 30 to 90min. The duration of intervention
sessions was 30min, as is usual for a physical therapy session
in the Netherlands. A detailed description of (the develop-
ment of) the Coach2Move strategy has been provided in an
earlier publication.22
The control intervention consisted of usual care physical
therapy.30 No instructions were given on treatment content,
frequency, and/or duration of the treatment episode. The
duration of both the intake session and each intervention
session of physical therapy was 30min. The duration of the
treatment episode was determined by the physical therapist
and varied according to the individual needs and recovery
of the patients. The contrast between the Coach2Move
strategy and usual care physical therapy is shown in Table 1.
Study parameters
Measurements were performed at baseline (t0), and 3 (t1)
and 6months after baseline (t2). The main study outcome is
PA at 6months as measured using the LASA Physical Activity
Questionnaire (LAPAQ).31 Two primary outcomes were
computed from the LAPAQ data: total PA and moderate in-
tensity PA in minutes per day. The latter outcome includes
all domains of the LAPAQ except light household chores
(i.e. cooking and washing dishes). This outcome was used be-
cause most PA standards prescribe moderate intensity PA
that does not include light household work.1,15 Secondary
outcomes included mobility (Get Up & Go Test in seconds,
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6min walking test on a 10m circuit, the 10m walking test—
walking speed in metres per second)32–34), quality of life
(Short Form-36, score 0–100),25 frailty (Evaluative Frailty
Index for PA, score 0.00–1.00),35 fatigue (Numeric Rating
Scale—fatigue, score 0–10),36 and patient-speciﬁc complaints
(score 0–10).37 The patient-speciﬁc complaints questionnaire
asks the patient to select the three most debilitating activity
problems (e.g. stair climbing, walking outside the house,
standing up from a chair, etc.) and to rate their experienced
disability on a scale of 0 (no disability) to 10 (not possible to
perform the activity mentioned). Multi-morbidity was regis-
tered using the Cumulative Illness Rating Scale-Geriatrics.38
To monitor falls, a question focusing on the number of falls
in the preceding 3months was asked.
For the economic evaluation, healthcare utilization was
registered by means of a questionnaire. The questionnaire
considered the type and number of health care used includ-
ing primary care, analgesics, hospital stay, nursing home stay,
use of residential facilities, home care (household and nursing),
and the purchase of assistive devices in the 3months prior
to administering the questionnaire (details: Appendices A
and B). The number of physical therapy sessions was regis-
tered by the physical therapy practices, including the prolonged
intake in the Coach2Move group. Besides analgesics, other
Table 1 Coach2Move strategy, implementation strategy, and similarities and contrasts between studied interventions
Intervention proﬁle Population Intervention
Proﬁle 1 (maximum
of four sessions)
Physically inactive
older adults without
physical constraints
to become (more)
physically active.
Coaching on self-management to become
more physically active.
Proﬁle 2 (maximum
of nine sessions)
Older adults with
minor or acute
mobility problems.
(1) Temporary physical therapy intervention to overcome
barriers to become (more) physically active (e.g. training of
strength, endurance, ﬂexibility or balance, fear reduction,
involving social environment, adaptation to personal factors,
advising walking aids, etc.). (2) Coaching on self-management
to become more physically active.
Proﬁle 3 (maximum
of 18 sessions)
Older adults with
moderate-to-severe
mobility problems
and speciﬁc
problems in
activities and
participation.
(1) Physical therapy intervention aimed at decreasing mobility
problems and problems in activity and participation. (2)
Temporary physical therapy intervention to overcome barriers
to become (more) physically active (e.g. training of strength,
endurance or balance, fear reduction, involving social
environment, advising walking aids, etc.). (3) Coaching on
self-management to become more physically active.
General Older adults
(≥70 years) with
mobility problems
with or without a
physically inactive
lifestyle who are at
risk to lose mobility
or an active lifestyle
in the near future.
Key elements of this six-step Coach2Move strategy: (1)
exploring the question for help and the barriers and facilitators
(physical, social, and environmental) in relation to physical
activity by using motivational interviewing techniques in an
extensive intake; (2) setting priorities in physiotherapy
diagnosis and treatment by using an algorithm that emphasizes
clinical reasoning; (3) shared decision-making on meaningful
treatment goals focused on abrogating barriers and increasing
physical activity; (4) coaching on self-management and self-
efﬁcacy to increase long-term results; (5) focus on meaningful
activities at home with help from family, friends, and/or
professionals; and (6) stratiﬁed intervention by using three
patient-tailored intervention proﬁles with a pre-deﬁned
number of intervention sessions.
Implementation strategy (1) Two-day training in Coach2Move strategy; (2) three follow-up meetings in which
problems encountered were discussed; (3) use of Coach2Move supportive electronic
patient ﬁle; (4) coaching in the execution of the Coach2Move strategy by researcher
(N. d. V.) during the RCT: N. d. V. checked all health records and contacted GPTs to
give instructions and advice, when necessary; and (5) possibility to consult researcher
(N. d. V.) with questions considering the execution of Coach2Move.
Similarities and
contrasts with usual
care physiotherapy
Similarities: individual intervention and use of physical therapy modalities (such as
training of strength, endurance, balance, ﬂexibility, functional training, etc.).
Contrast: using an extensive intake based on a decision algorithm (clinical reasoning),
using motivational interviewing, setting meaningful goals on increasing (adherence
for) PA, enhancing self-efﬁcacy and self-management, giving feedback on progress,
using personal and environmental factors, using intervention proﬁles with a pre-
deﬁned number of consults (based on expected recovery), and intervention given by a
PT with additional education in geriatrics and Coach2Move.
GPT, geriatric physical therapist; PA, physical activity; PT, physical therapist; RCT, randomized controlled trial.
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medications were not taken into account because we did
not expect there to be any beneﬁt for medication con-
sumption as a consequence of physical therapy over a
6months period.
Statistical analysis
The study was designed to have 80% power at a signiﬁcance
level of 0.05 and was based on data from our pilot study and
literature. The necessary sample size was 130 patients taking
into account a dropout rate of 20%. The sample size calcula-
tion has been described in detail elsewhere.23 We expected
the Coach2Move strategy to increase PA 1.68 times more
than usual care physical therapy. This expectation was based
on the ﬁndings of our pilot study (3.35-fold increase in PA),22
and improvements in PA noted in the literature based on a
standard exercise intervention (1.2-fold increase).39 Because
we hypothesized a possible overestimation of the effects
found in our pilot study as compared with other studies, and
taking into account possible contamination, the expected
difference in effectiveness was determined.23
Statistical analyses were performed based on the intention
to treat principle. Descriptive statistics were used to describe
the study groups. Linear mixed models with therapy practice
as a random factor and repeated measurements structure at
subject level (baseline, 3 and 6months) were used to take
into account correlation of measurements over time. Each
of the outcomes was added as a dependent variable, and
group was taken as a ﬁxed variable. Physical therapy practice
was taken as random effect in this model to account for
clustering of patients. Mean differences between groups at
each measurement point are presented with 95% conﬁdence
intervals. Effect sizes (Cohen’s d) were calculated by dividing
the mean difference in effect between the Coach2Move and
the usual care physical therapy group by the pooled standard
deviation. In a post hoc analysis, we compared the proportion
of patients who did not fulﬁl the PA standard at baseline but
who did so at 6months (responders), and we determined
the proportion of participants that reported one or more falls.
The number of responders and fallers was compared between
groups using a χ2 test.
Cost-utility analysis was performed from a societal per-
spective. Cost prices were determined using standard unit
cost prices according to the Dutch guidelines for costing
research,40 or real cost prices were determined using
activity-based costing (Appendix A). Costs were computed
by multiplying the cost prices with the usage frequency as
reported by the patients in the healthcare utilization ques-
tionnaire with the exception of the frequency of physical
therapy treatment that was based on registration by the
involved physical therapy practices. The cost price for physical
therapy in the Coach2Move group was higher than the cost
price for usual care physical therapy conforming to the higher
rates for specialized physical therapists as advised by the
Dutch Society for Physical Therapy (Appendix A). The extra
time taken for the prolonged intake in the Coach2Move
group was included in the analyses. Only costs that could
be related to physical therapy were taken into account. For
example, orthopaedic surgery was included, whilst chemo-
therapy was excluded. In respect of drug use, only
analgesics were taken into account. Quality of health status
was analysed by transforming the SF-36 scores to SF-6D
scores that were subsequently transformed into quality-
adjusted life years (QALYs) using the trapezium method.41
This means that the total change in SF-6D score was approx-
imated as a trapezoid: the area under the curve was
calculated by dividing the curve into aggregated trapeziums
or segments. Because we needed to correct for coincidental
unbalanced allocation in an observed confounder (baseline
cost), as well as the potential cluster effects (physical therapy
practice), a regression-based approach to cost-effectiveness
analysis was applied.42 Therefore, the net monetary beneﬁt
statistic (NMB) was used, deﬁned as follows: NMB=willingness
to pay (WTP * Effect)Costs. QALY was used as the indicator
of effect, and six threshold values of WTP were deﬁned
(Table 5). The decision rule states that the option with the
highest NMB is the most cost effective given the speciﬁc
WTP.42 NMBs were calculated at patient level, and subse-
quently, NMB differences between groups for different WTP
thresholds were statistically tested using mixed model analy-
ses in which physical therapy practice was included as a
random factor; a correction for difference in baseline values
(costs and SF-6D) was applied and bootstrapped 200 times.
In a post hoc analysis, the proportion of patients that had
to deal with one or more major incident (visit emergency
department, hospital admission, nursing home admission,
and temporary stay in residential care facility) or died was
compared between groups using a χ2 test.
Results
Between September 2012 and November 2013, 361 poten-
tially eligible patients were informed about the study
(Figure 1). Participation was declined by 122 patients, and
109 patients did not fulﬁl the inclusion criteria. One hundred
and thirty eligible patients were randomly assigned to the
intervention group (n = 64) and the control group (n = 66).
One of the patients assigned to the usual care physical
therapy group was excluded after randomization based on
additional information about the patients’ health status that
did not meet the inclusion criteria. In both intervention
groups, one patient declined the allocated intervention
because the health insurance did not cover treatment. Some
patients in both groups were not able or willing to perform
the walking tests at follow-up measurement. There were no
missing data on the questionnaires.
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Demographic characteristics of participants are shown in
Table 2. There were no statistically signiﬁcant differences
between groups at baseline.
The primary and secondary outcomes at the 3 and
6months follow-up are presented in Table 3. The estimated
between-group difference at 6months on the primary out-
come was 17.9min per day (95% CI 4.0 to 34.9, P = 0.012)
for moderate intensity PA and 14.1min per day (95% CI
6.6 to 34.9, P = 0.182) for total PA in favour of the
Coach2move intervention. For frailty, the estimated differ-
ence was 0.03 (95%CI: 0.06 to 0.00; P = 0.027). The
effect size (Cohen’s d) for total PA was 0.23 (95%CI: 0.14,
0.60), for moderate intensity PA 0.38 (95% CI: 0.01, 0.74),
and for frailty, 0.23 (95% CI: 0.59, 0.13). Signiﬁcant
within-group differences were found on all outcomes except
for the psychological subscale of the SF-36 and fatigue in
the Coach2Move group. The usual care physical therapy
group improved signiﬁcantly on total PA, all mobility-related
outcomes, the physical subscale of the SF-36, and patient-
speciﬁc complaints (Table 3).
Post hoc analyses showed no difference in the proportion
of participants that reported one or more fall incidents. In
the Coach2Move group, 18 participants fell once during the
6months follow-up, and nine participants had more than
one fall incident. For the usual care physical therapy group,
13 participants reported one fall incident, and nine fell more
than once. The number of patients who were not physically
active at moderate intensity for 30min per day at baseline,
but were at 6months, was signiﬁcantly higher in the
Coach2Move group (35%) compared with the usual care
physical therapy group (18%) [χ2 test (P = 0.037)].
Tables 4 and 5 show the results in terms of cost effective-
ness. Treatment according to the Coach2Move strategy
resulted in both statistically signiﬁcant savings of €848.8
Figure 1 Trial ﬂowchart.
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(95% CI: 1607 to 90, P= 0.028) and higher QALYs (mean
difference: 0.02, 95% CI: 0.00 to 0.03, P= 0.011). Table 5 shows
that the NMB of the Coach2Move approach was higher than
the NMB of the usual care physical therapy group at every
WTP threshold of the pre-speciﬁed range. The incremental
NMB was in favour of the Coach2Move strategy with a proba-
bility of the Coach2Move strategy being cost effective com-
pared with usual care physical therapy of over 95% (Figure 2).
Frequencies of healthcare use are laid out in Appendix B. The
mean number of physical therapy sessions was signiﬁcantly
lower (P=0.003) in the Coach2Move group (mean: 11 including
prolonged intake, SD: 4.5; median: 11) than in the usual care
physical therapy group (mean: 17, SD: 15.0; median: 12). At the
ﬁrst follow-up visit after 3months (t1), 55% (n=35) of the
Coach2Move participants had ﬁnished their physical therapy
treatment. In the usual care group, 36% (n=24) had ﬁnished
after 3months. At the end of this study (t2-6months), all but
one Coach2Move participant no longer received physical therapy
treatment. Four patients in the usual care physical therapy con-
tinued to visit their physical therapist. On average, the usual care
physical therapy group had a higher dosage of treatment than
the Coach2Move group. The proportion of patients who had
to deal with one or more major incidents (visit to emergency
department, hospital admission, nursing home admission, and
temporary stay in residential care facility) or who had died
was signiﬁcantly higher in the usual care physical therapy
group than in the Coach2Move group: 22% and 8%,
respectively (P=0.028).
Discussion
Our study shows that the patient-centred Coach2Move
strategy is effective in enhancing moderate intensity PA and
in reducing frailty in older adults with mobility problems. In
addition, Coach2Move has lower costs, higher beneﬁts, and
fewer incidents compared with usual physical therapy
management.
Both studied interventions used physical therapy strategies
(e.g. strength training, ﬁtness training, and balance training)
and were effective in increasing mobility that is a clear and
objective indicator of muscle functioning (sarcopenia) and
total physical functioning. Older adults in the Coach2move
group, however, were able to use these capacities to increase
activities in daily life over a period of 6months and to
decrease frailty, whereas in 55% of cases, the intervention
had already been completed within 3months. The
Coach2Move intervention was tailored to personal impair-
ments, disabilities, and participation problems that were
systematically diagnosed in an extensive intake. The patient
Table 2 Demographic characteristics and baseline scores
Coach2Move (n=64) Usual care PT (n=65)
Demographic characteristics n (%) or mean (SD) n (%) or mean (SD)
Age (years) 78.4 (5.5) 78.6 (5.5)
Men 16/64 (25%) 20/65 (31%)
CIRS co-morbidity score, higher score, and more co-morbidity 7.27 (3.2) 6.25 (2.6)
Educational level
High 5/49 (10%) 5/60 (8%)
Middle 7/49 (14%) 10/60 (15%)
Low 37/49 (76%) 45/60 (77%)
Marital status: having a partner 31/64 (48%) 35/65 (54%)
Living in a residential care facility 3/64 (5%) 2/65 (3%)
Post-operative status 15/64 (23%) 13/65 (20%)
Baseline values at the outcome measures
Total PA (minutes per day) 87.0 (56.6) 87.9 (61.0)
Moderate intensity PA (minutes per day) 28.8 (29.7) 35.4 (35.4)
Frailty (0.00–1.00, higher score, more frailty) 0.34 (0.1) 0.30 (0.1)
Quality of life and physical subscale (0–100, higher score, and better quality of life) 30.8 (9.3) 34.0 (10.8)
Quality of life and mental subscale (0–100, higher score, and better quality of life) 56.7 (8.8) 56.2 (10.8)
Walking speed (m/s) 0.83 (0.3) 0.83 (0.3)
Mobility (s, Get Up & Go Test) 34.7 (15.0) 35.1 (18.1)
Walking distance (m) 225.1 (117.3) 240.4 (102.9)
Patient-speciﬁc complaints (0–10, higher score, more complaints) 7.6 (3.1) 7.2 (2.1)
Fatigue (0–10, higher score, more fatigue) 5.2 (2.2) 5.2 (2.2)
Primary care costs (€) 88.54 (161.6) 71.98 (128.3)
Physical therapy costs (€)a 30.80 (135.5) 23.82 (87.6)
Medication costs (€) 19.52 (125.3) 1.45 (4.2)
Hospital care costs (€) 1875.06 (4254.5) 1639.69 (3642.2)
Outpatient care costs (€) 2392.09 (8852.3) 2553.20 (6268.4)
Home care costs (€) 1213.41 (2027.4) 1026.43 (1477.4)
Assistive devices costs (€) 113.09 (415.3) 38.49 (150.2)
Total costs (€) 6466.60 (11154.1) 5398.06 (8321.3)
No signiﬁcant between-group differences were observed at baseline. Costs apply to the 3months preceding baseline.
CIRS, cummulative illness rating scale; PA, physical activity; PT, physical therapist; SD, standard deviation.
aIt is included in ‘primary care’.
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was involved in clinical decision-making, and, most impor-
tantly, the physical and social environment was involved in
the treatment process, a factor that probably supported the
retention and, sometimes even the improvement, in function-
ing, even after physical therapy had ended.
Exercise and PA are thought to be the most important
interventions to ameliorate frailty because of the positive
inﬂuence on multiple frailty-related factors such as muscle
strength, activity level, and walking speed.5,7 The direct
effect on frailty is an important and promising result of
our study. Most studies only consider physical aspects of
frailty, whilst research has shown that psychological and
social factors also inﬂuence frailty status.34 A recent study
showed that a PA intervention reduced physical frailty in
older adults and emphasized the potential importance of
PA in reducing frailty and improving health status in older
Table 4 Aggregated costs and quality-adjusted life years at 6months
Coach2Move: aggregated
outcome at 6months
(n=60)
Usual care PT: aggregated
outcome at 6months
(n=55)
Mean difference
between groups
(95% CI)
P
value
Mean 95% CI Mean 95% CI
Primary care (€) 574.6 453.2 to 696.1 671.2 545.8 to 796.7 96.6 (231.0 to 37.7) 0.157
PT (€)a 467.7 345.2 to 590.3 569.9 443.5 to 696.3 102.2 (229.7 to 25.3) 0.115
Analgetics 5.7 28.5 to 39.9 37.2 1.6 to 72.8 31.5 (77.9 to 15.0) 0.182
Hospital care (€) 308.6 13.8 to 603.4 372.0 64.1 to 679.9 63.4 (489.9 to 363.1) 0.77
Outpatient care (€) 9.5 240.5 to 259.5 269.6 8.4 to 530.8 260.1 (622.4 to 102.2) 0.158
Home care (€) 1785.5 1405.9 to 2165.2 2076.4 1679.8 to 2473.0 290.8 (840.7 to 259.0) 0.28
Assistive devices (€) 30.4 17.6 to 78.4 51.8 1.8 to 101.8 21.4 (89.0 to 46.2) 0.53
Total (€) 2675.6 1911.5 to 3439.7 3524.4 2730.2 to 4318.6 848.8 (1607 to 90) 0.028
QALYs (0.00–0.50) 0.37 0.36 to 0.39 0.35 0.34 to 0.37 0.02 (0.00 to 0.03) 0.011
Costs are estimated based on a linear mixed model with adjustments for baseline. Total costs and QALYs are based on a linear mixed
model with adjustments for baseline values that was bootstrapped 200 times. A negative mean difference represents lower costs for
the Coach2Move group; a positive mean difference represents higher costs for the Coach2Move group. A positive difference in QALY in-
dicates an improvement of the Coach2Move group compared with the usual care group.
Mean difference on all outcomes favour the Coach2Move group. Costs in €.
CI, conﬁdence interval; PT, physical therapist; QALYs, quality-adjusted life years.
aIt is included in ‘primary care’.
Table 5 Net monetary beneﬁt and incremental net monetary beneﬁt
WTP (€) Coach2Move Usual care PT
Mean (95% CI) Mean (95% CI) Incremental NMB P value
2000 1931 (2702 to 1161) 2800 (3601 to 1999) 869 (120 to 1618) 0.023
5000 816 (1599 to 33) 1698 (2513 to 885) 882 (153 to 1612) 0.018
10 000 1042 (236 to 1848) 137 (700 to 975) 905 (117 to 1993) 0.024
20 000 4759 (3903 to 5614) 3810 (2921 to 4698) 949 (72 to 1827) 0.034
30 000 8475 (7565 to 9386) 7482 (6536 to 8427) 994 (113 to 1875) 0.027
50 000 15 909 (14 878 to 16 940) 14 825 (13 754 to 15 897) 1083 (111 to 2277) 0.075
P values are based on linear mixed model analysis adjusted for baseline values that was bootstrapped 200 times.
An NMB> 0 represents a cost-effective intervention.
The incremental NMB gives the difference between the NMB of the Coach2Move group compared with the usual care PT group. A positive
value is in favour of the Coach2Move group.
CI, conﬁdence interval; NMB, net monetary beneﬁt; PT, physical therapist; WTP, willingness to pay.
Figure 2 Incremental net monetary beneﬁt and acceptability curve.
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adults.8 Our study supports these ﬁndings and is the ﬁrst
study to show a reduction in frailty as measured on mul-
tiple dimensions. Because frailty is a powerful predictor of
adverse health outcome, reducing frailty could possibly
have large positive effects on health status and for a lon-
ger period of time. However, we do not know if the mag-
nitude of the difference in frailty score is large enough to
be clinically relevant. However, it should be mentioned
that both groups showed signiﬁcant improvements in mo-
bility compared with baseline, which were systematically
larger in the Coach2Move group (although not signiﬁcant).
This needs to be further assessed in future longitudinal
studies.
In a meta-analysis of our research group, we could not
conﬁrm an increase in PA as a result of physical exercise
therapy in community-dwelling older adults with mobility
problems and/or multi morbidity.2 A recent study that
compared a group exercise programme with a home-
based exercise programme coached by a mentor with a
usual care control group in older adults over 65 years
old found an increase of 15min of PA per day in the
group exercise programme and a 9% increase in the pro-
portion of participants that fulﬁlled PA standards.43 In our
study, we found signiﬁcant improvements on all outcomes
in both groups. However, we found a much larger in-
crease in the Coach2Move group: the Coach2Move group
increased moderate intensity PA with over 30min per day.
Given the internationally accepted PA standards of 30min
a day,1 these ﬁndings are likely to be clinically relevant. A
proportion of 35% of the participants in the Coach2Move
group did not fulﬁl the PA standard at baseline but did so
at 6months. In addition, the participants in the present
study were of higher age and had already existing mobil-
ity problems. This means that we judge the increased PA
as clinically relevant when taking into account the rela-
tively high age and high number of co-morbidities.
In contrast to other studies, we also found healthcare cost
savings. At baseline, both groups had made huge healthcare
costs in the preceding 3months. At 6months follow-up, the
costs had reduced enormously in both groups, but signiﬁ-
cantly more in the Coach2Move group. These large
differences between baseline and follow-up costs may be
explained by the fact that a number of patients started
physical therapy after a fall incident, a hospital admission,
or surgery that increased costs. In addition, we also believe
that treatment by a physical therapist reduces the number
of other health professionals needed and improves mobility
and thereby reducing, for example, the risk of fall incidents.
Moreover, the Coach2Move strategy focuses on self-
management in which patients are empowered to take
responsibility for their own health, possibly explaining the
additional cost advantage for the Coach2Move group.
Inconsistent results have been found in respect of the
effectiveness of patient-centred care.44,45 It has been shown
that standard protocols are not sufﬁcient to treat older adults
with multi-morbidity.46 Integrating the principles of patient-
centred care into clinical reasoning can offer a solution for
physical therapy by combining the knowledge from
evidence-based physical therapy protocols, the clinical
experience of physical therapists, and patient preferences
and needs. Our study shows that a patient-centred physical
therapy approach is feasible and effective for older adults
with mobility problems, thus emphasizing the importance
of a shift towards patient-centred care in order to improve
healthcare efﬁciency.
Contamination between the two participating physical
therapists in one practice might have been an issue. We
believe that the risk of contamination was minimized because
speciﬁc skills and knowledge are needed to apply the
Coach2Move strategy. Even though the Coach2Move strategy
uses the same exercise modalities and therefore, intuitively,
seems very similar to usual care physical therapy, research
has shown that physical therapists do not generally set
patient-centred goals when improving PA and physical
therapists are not trained to speciﬁcally stimulate shared
decision-making and to apply coaching techniques that in-
crease self-management.47
Even though we applied broad inclusion and exclusion
criteria as present in typical daily clinical practice, we
had some difﬁculty with the inclusion of patients. Many
potential participants declined to participate mostly be-
cause they preferred a speciﬁc therapist and did not want
to be randomized, which possibly leads to selection bias
and may limit the generalizability of our study ﬁndings.
Also, informal caregivers were not taken into account in
the cost-effectiveness analysis because we did not expect
informal caregivers to make a difference to the incremen-
tal cost-effectiveness analysis. Consequently, the shown
cost-effectiveness of the Coach2Move strategy is mostly
based on costs from a healthcare perspective and, to a
lesser extent, on costs from a societal perspective. Retro-
spectively, it would have been better to include informal
caregivers in our cost-effectiveness evaluation. Another
limitation of the present study is the lack of a control group
that did not receive an intervention to account for natural
recovery. In addition, the follow-up period of 6months is
relatively short.
Our study shows that older adults with mobility problems
are able to safely increase PA in their own environment and
decrease their level of frailty when they are adequately
coached by a physical therapist that has the knowledge and
skills to take health status, personal needs, preferences, facil-
itators, and barriers into account. Moreover, this study
emphasizes the potential cost-effectiveness of patient-
centred care in frail–older adults. The results of this study
justify a future study with long-term follow-up to replicate
the present ﬁndings. In addition, the Coach2Move strategy
could be used as an example to incorporate patient-centred
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strategies in daily physical therapy care. The positive effect
found on frailty status emphasizes the importance of PA pro-
motion in older adults, and therefore PA should be encour-
aged by health authorities. We have shown that not only
healthy older adults beneﬁt from PA but also frail–older
adults with mobility limitations.
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